MBICR focuses on research projects with excellent potential for both basic sciences as well as translational science applications. Our mission is to harness advanced technologies to increase our understanding of cancer cell biology. We will use the gained knowledge to devise interventions that are more effective and have fewer side-effects than conventional cancer therapies. We are committed to moving our most promising breakthroughs from the laboratory to clinical testing along multiple avenues both within the Institute community and with partners worldwide. We have dedicated teams to manage every step required to translate the fundamental discoveries into clinical interventions that will benefit patients. We will also help private start-up companies that will focus on a promising breakthrough with commercial potential that might generate financial returns to fund additional fundamental research.
The MBICR was inaugurated on November 18, 2016, at 9 Keyuan Boulevard South, Gaoxing District, Chengdu. Adjacent to Tianfu Life Science Park, this campus occupies a small space of 8,611 sq ft and is made up of a tight network of laboratories where faculty and staff are engaged in establishment of core research facilities, such as natural products libraries, functional genomics, high throughput/content screening, medicinal chemistry, preclinical therapeutics, antibody and viral products, cell culture and biomedical statistics.
The MBICR is constructing a four-story research building at Chengdu Tianfu International Bio-town. The Bio-town locates next to major transport sites and facilities, allowing our researchers in the town can travel?regionally and internationally with ease. Furthermore, this prime location is in proximity to more than ten academic powerhouses that provide?an extraordinary supply of highly trained, compassionate and professional workers. Once the project is completed by the end 2018, our research space will increase to 51,666 sq ft. MBICR Bio-town will be a teaching and?research campus with a daily population of about 100 MBICR faculty, staff, students and other visitors. The campus will also serve as headquarters for MBICR leaders.
MBICR NPL Center
The MBICR has leased a facility in the city of Chengdu to expand its capacity in constructing natural product libraries that are compatible with high-throughput screening. The facility covers two acres and provides 7,5347 sq ft research space. The site will be innovated and dedicated to manufacturing natural product libraries. MBICR researchers here will utilize state-of-art equipment such as ASE, supercritical fluid extraction, automatic sample concentrator, SPE workstations, analytic and preparative HPLC, and LC-MS-MS to establish quality standards for select natural products, perform fractionation of extracts and manufacture libraries of natural compound/extract in biochips.
As part of long-range planning, MBICR will launch a botanic garden, which covers an area of more than one hundred acres. The garden will be planted with more than ten thousand species of plants for the research, education and enjoyment of our faculty, staff, and students. Many of these plants have a long history of use in traditional and folk medicine in a number of different cultures. Others are known to contain chemical compounds that may be of particular interest to medicine.